Literature DB >> 21414088

Connectivity between mitochondrial functions and psychiatric disorders.

Jana Hroudová1, Zdeněk Fišar.   

Abstract

Mitochondria provide most of the energy production in cells. They are involved in the regulation of free radicals, calcium buffering, and redox signaling and take part in the intrinsic pathway of apoptosis. Mutations or polymorphisms of mitochondrial DNA, mitochondria-mediated oxidative stress, decrease of adenosine triphosphate production, changes of intracellular calcium and oxidative stress are concerned in various diseases. There is increasing evidence that impaired functions of mitochondria are associated with mood disorders. It is suggested that disturbed energetic metabolism and/or reactive oxygen species production take part in the pathophysiology of mood disorders and could participate in the therapeutic effects or side-effects of antidepressants and mood stabilizers.
© 2011 The Authors. Psychiatry and Clinical Neurosciences © 2011 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414088     DOI: 10.1111/j.1440-1819.2010.02178.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  12 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 2.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

3.  Brain cytochrome-c-oxidase as a marker of mitochondrial function: A pilot study in major depression using NIRS.

Authors:  Lisa Holper; Martin J Lan; Patrick J Brown; Elizabeth M Sublette; Ainsley Burke; John J Mann
Journal:  Depress Anxiety       Date:  2019-05-21       Impact factor: 6.505

4.  Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Pharmacol Biochem Behav       Date:  2012-03-10       Impact factor: 3.533

5.  Distinct proteomic profiles in prefrontal subareas of elderly major depressive disorder and bipolar disorder patients.

Authors:  Yang-Jian Qi; Yun-Rong Lu; Li-Gen Shi; Jeroen A A Demmers; Karel Bezstarosti; Erikjan Rijkers; Rawien Balesar; Dick Swaab; Ai-Min Bao
Journal:  Transl Psychiatry       Date:  2022-07-11       Impact factor: 7.989

Review 6.  Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF?

Authors:  A Markham; R Bains; P Franklin; M Spedding
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

7.  Effect of Novel Antipsychotics on Energy Metabolism - In Vitro Study in Pig Brain Mitochondria.

Authors:  Matej Ľupták; Zdeněk Fišar; Jana Hroudová
Journal:  Mol Neurobiol       Date:  2021-08-08       Impact factor: 5.590

Review 8.  The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.

Authors:  Anna Giménez-Palomo; Seetal Dodd; Gerard Anmella; Andre F Carvalho; Giselli Scaini; Joao Quevedo; Isabella Pacchiarotti; Eduard Vieta; Michael Berk
Journal:  Front Psychiatry       Date:  2021-07-06       Impact factor: 4.157

9.  Control mechanisms in mitochondrial oxidative phosphorylation.

Authors:  Jana Hroudová; Zdeněk Fišar
Journal:  Neural Regen Res       Date:  2013-02-05       Impact factor: 5.135

10.  Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study.

Authors:  C N Black; B W J H Penninx; M Bot; A O Odegaard; M D Gross; K A Matthews; D R Jacobs
Journal:  Transl Psychiatry       Date:  2016-02-23       Impact factor: 7.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.